![Sue Currie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sue Currie is currently the Chief Operating Officer at Virion Therapeutics LLC since 2021.
Previously, she worked as the Vice President & Head-Medical Affairs at Nektar Therapeutics.
Dr. Currie completed her undergraduate degree at the University of Saskatchewan, her graduate degree at the University of Phoenix, and her doctorate at the University of San Francisco.
| Sociétés | Poste | Début |
|---|---|---|
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Directeur des opérations | 22/11/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
